Ocata Therapeutics ocata.co


Public lists: Pharma Startups (4733)

Ocata Therapeutics (NASDAQ: OCAT), formerly Advanced Cell Technology, is a clinical stage biotechnology company focused on the development and commercialization of new therapies in the field of regenerative medicine.

Ocata Therapeutics (NASDAQ: OCAT), formerly Advanced Cell Technology, is a clinical stage biotechnology company focused on the development and commercialization of new therapies in the field of regenerative medicine.

Company (Merged)

Phone: 508-756-1212

Fax:

33 Locke Drive

Marlborough, 01752
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Ocata Therapeutics $2.2M Feb 10, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Ocata Therapeutics Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Hemangio-colony forming cells Sep 29, 2015 Apr 10, 2018 Patent
Modalities for the treatment of degenerative diseases of the retina Apr 21, 2015 Aug 15, 2017 Patent
Hemangio colony forming cells and non-engrafting hemangio cells May 06, 2009 Aug 09, 2016 Patent
Modalities for the treatment of degenerative diseases of the retina Mar 27, 2014 Nov 24, 2015 Patent
Modalities for the treatment of degenerative diseases of the retina Mar 27, 2014 Nov 10, 2015 Patent
See all 20 patents